Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 16 Jun 2025

Deciphering the circadian rhythm in colorectal cancer: a bibliometric analysis of research landscape and trends

in Cancer Molecular Targets and Therapeutics

Linzi Chen
Zhongjie Wang
Ningkun Xiao
Jinhui Liu
Yuhan Tao
Sifang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1591257

552 views

Original Research

Published on 12 Jun 2025

CD4 T cells correlate with better prognosis in medulloblastoma

in Cancer Molecular Targets and Therapeutics

Jin Zhang
Siqi Ren
Shuting Li
Yuan Wang
Lulu Wan
Wenchao Gao
Huaying Sun
Xiaojun Gong
Miao Li
Yanling Sun

Frontiers in Oncology

doi 10.3389/fonc.2025.1593329

799 views

Original Research

Published on 12 Jun 2025

Targeting GJB4 to inhibit tumor growth and induce ferroptosis in pancreatic cancer

in Cancer Molecular Targets and Therapeutics

Xiangru Zheng
Wenjun Li
Xiaoli Li
Qianyi Yao
Luquan Zheng
Rongrong Fan
Ping Bie

Frontiers in Oncology

doi 10.3389/fonc.2025.1585236

803 views

Original Research

Published on 11 Jun 2025

S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker

in Cancer Molecular Targets and Therapeutics

Haibo Wang
Rongchao He
Deng Liu
Jun He
Zhong Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1590128

921 views

Original Research

Published on 10 Jun 2025

Effective imaging examination evaluation method for surgical pathological complete responds of head and neck squamous cell carcinoma after neoadjuvant immunochemotherapy

in Cancer Molecular Targets and Therapeutics

Yudong Ning
Yixuan Song
Yuqin He
Han Li
Yang Liu
Shaoyan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1585194

566 views

Original Research

Accepted on 09 Jun 2025

High expression of SOX9 is a diagnostic and prognostic indicator of glioma

in Cancer Molecular Targets and Therapeutics

Libo Xu
Zhenhao Wang
Mao Li
Qingsong Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1531937

113 views

Systematic Review

Accepted on 06 Jun 2025

Prognostic and Clinicopathological Value of DBC1 Expression in Human Cancers: A Systematic Review and Meta-Analysis

in Cancer Molecular Targets and Therapeutics

Haojia Wang
Xinhong Cheng
Xianzhuo Zhang
Yong Wang
Shuo Gao
Fanghui Ding
Xiaojing Song
Dandan Li
Haixu Ni
Yang Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1584622

Review

Published on 06 Jun 2025

Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence

in Cancer Molecular Targets and Therapeutics

Divya Vishambhar Kumbhakar
Lucky Thakkar
Chetana Akhand
Shehna Sharaf
Geeta K. Vemuganti

Frontiers in Oncology

doi 10.3389/fonc.2025.1499283

2,717 views

Original Research

Published on 04 Jun 2025

Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis

in Cancer Molecular Targets and Therapeutics

Ming Liu
Guixin Ding
Gonglin Tang
Shangjing Liu
Qiancheng Mao
Xidong Wang
Qingsong Zou
Jitao Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1547067

796 views

Review

Published on 04 Jun 2025

Research progress on NUSAP1 and its role in digestive system neoplasms

in Cancer Molecular Targets and Therapeutics

Shangui Fu
Yuting Zhuo
Tao Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1582361

845 views

Original Research

Published on 30 May 2025

Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer

in Cancer Molecular Targets and Therapeutics

Mohammed Ali Alshehri
Hadil Alahdal
Akram Ahmed Aloqbi
Afnan Mohammed Shakoori
Ghadir Sindi
Rehab M. Bagadood
Nida Alsaffar
Mohammad Ahmad Alobaidy
Noof Abdulrahman Alrabiah
Md Khursheed

Frontiers in Oncology

doi 10.3389/fonc.2025.1598883

747 views

Original Research

Published on 30 May 2025

Metabolic profiling of glioblastoma and identification of G0S2 as a metabolic target

in Cancer Molecular Targets and Therapeutics

Jianlei Kang
Yujie Xu
Qitai Zhao
Ying Wang
Zhenyan He
Xin Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1572040

1,000 views

Mini Review

Published on 29 May 2025

Advancing targeted therapy for colorectal cancer: harnessing ligand-directed enzyme prodrug therapy for highly specific interventions

in Cancer Molecular Targets and Therapeutics

Hend Al-Jaber
Kabir H. Biswas
Layla Al-Mansoori

Frontiers in Oncology

doi 10.3389/fonc.2025.1570712

847 views

Correction

Published on 29 May 2025

Corrigendum: MiR-21 and let-7 cooperation in the regulation of lung cancer

in Cancer Molecular Targets and Therapeutics

Jinquan Bai
Zhenzhou Shi
Shuting Wang
Hong Pan
Tong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1602462

351 views

Review

Published on 29 May 2025

Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options

in Cancer Molecular Targets and Therapeutics

Xin-xian Cai
Zhe-zhong Zhang
Xiao-xiao Yang
Wen-rui Shen
Liu-wei Yuan
Xi Ding
Ying Yu
Wen-yu Cai

Frontiers in Oncology

doi 10.3389/fonc.2025.1579423

993 views

Original Research

Accepted on 27 May 2025

Outcomes and prognostic factors of alternative treatment regimens for angioimmunoblastic T-cell lymphoma: a retrospective analysis

in Cancer Molecular Targets and Therapeutics

Jiaqin Yan
Jiebing Wang
Junhui Zhang
Xudong Zhang
Lei Zhang
Mingzhi Zhang
Zunmin Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1585013

141 views